SCHEMBL23810503

SCHEMBL23810503

Cc1sc(NC(=O)[C@H](C)NC(=O)OC(C)(C)C)c(C(=O)c2ccc(Cl)cc2)c1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.51
▸ MAPT P10636 8/20 0.51
▸ LMNA P02545 4/20 0.51
▸ BRD4 O60885 1/20 0.51
▸ HPGD P15428 7/20 0.46
▸ PLA2G1B P04054 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ ATG4B Q9Y4P1 1/20 0.46
▸ PPARG P37231 1/20 0.44
▸ PPARA Q07869 1/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ GRIN2C Q14957 2/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ TP53 P04637 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ XBP1 P17861 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23348597 1.00 ALDH1A1 (0.51) ALDH1A1MAPTLMNABRD4HPGD
SCHEMBL30012539 0.87 BRD4 (0.49) ALDH1A1MAPTLMNABRD4HPGD
SCHEMBL31498653 0.87 BRD4 (0.49) ALDH1A1MAPTLMNABRD4HPGD
SCHEMBL31515466 0.86 BRD4 (0.48) ALDH1A1MAPTLMNABRD4HPGD
SCHEMBL23801148 0.85 ALDH1A1 (0.58) ALDH1A1MAPTLMNABRD4HPGD
SCHEMBL23801147 0.85 ALDH1A1 (0.58) ALDH1A1MAPTLMNABRD4HPGD
SCHEMBL872773 0.79 BRD4 (0.49) ALDH1A1MAPTLMNABRD4HPGD
SCHEMBL872772 0.79 BRD4 (0.49) ALDH1A1MAPTLMNABRD4HPGD
SCHEMBL30012531 0.78 ALDH1A1 (0.60) ALDH1A1MAPTLMNABRD4HPGD
SCHEMBL30013082 0.77 ALDH1A1 (0.46) ALDH1A1MAPTLMNAHPGDPLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542273-B2 Amide compound having bet proteolysis-inducing action and medicinal application thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2023-01-03 — — US disclosed
US-11542273-B2 Amide compound having bet proteolysis-inducing action and medicinal application thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2023-01-03 — — US disclosed
US-20210284654-A1 AMIDE COMPOUND HAVING BET PROTEOLYSIS-INDUCING ACTION AND MEDICINAL APPLICATION THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2021-09-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11542273-B2 Amide compound having bet proteolysis-inducing action and medicinal application thereof BET1, BRD4, PHKB ALDH1A1 4054/4885MAPT 3109/4885LMNA 2073/4885
US-20210284654-A1 AMIDE COMPOUND HAVING BET PROTEOLYSIS-INDUCING ACTION AND MEDICINAL APPLICATION THEREOF BET1, BRD4, PHKB ALDH1A1 4055/4885MAPT 3143/4885LMNA 1941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback